HCA Healthcare, Inc. $HCA is Alamar Capital Management LLC’s 9th Largest Position

Alamar Capital Management LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,006 shares of the company’s stock after selling 567 shares during the quarter. HCA Healthcare comprises about 2.7% of Alamar Capital Management LLC’s investment portfolio, making the stock its 9th largest holding. Alamar Capital Management LLC’s holdings in HCA Healthcare were worth $4,494,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the 1st quarter worth approximately $26,000. Saudi Central Bank purchased a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $26,000. WPG Advisers LLC purchased a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $27,000. Atwood & Palmer Inc. purchased a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $28,000. Finally, Bartlett & CO. Wealth Management LLC lifted its holdings in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock valued at $31,000 after purchasing an additional 80 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 0.8%

HCA Healthcare stock opened at $404.11 on Monday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The firm has a market capitalization of $94.56 billion, a price-to-earnings ratio of 16.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock’s fifty day moving average is $376.92 and its two-hundred day moving average is $357.19.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Wolfe Research lowered HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. JPMorgan Chase & Co. raised their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Barclays dropped their target price on HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating for the company in a research report on Monday, July 28th. Stephens raised HCA Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Finally, Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.